Plus Therapeutics, Inc. | CYTX - Operating Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Plus Therapeutics, Inc.

Plus Therapeutics, Inc. reported $5.23M in Operating Expenses for its fiscal quarter ending in March of 2023.


Operating Expenses Change
Baxter International BAX:US USD 3.46B 233M
Dr.Reddys Laboratories DRRD:IN INR 50.59B 1.16B
Haemonetics HAE:US USD 269.16M 7.14M
Infinity Pharmaceuticals INFI:US USD 12.24M 2.16M
Merrimack Pharmaceuticals MACK:US USD 447K 160K
Mirati Therapeutics MRTX:US USD 200.99M 11.67M
Northwest Biotherapeutics NWBO:US USD 15.25M 6.06M
Plus Therapeutics, Inc. CYTX:US USD 5.23M 497K
Starpharma Holdings Ltd SPL:AU AUD 9.99M 835K
Sun Pharmaceuticals SUNP:IN INR 89.44B 502.6M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 3.66B 1.08B